Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 25,700
+1,050 (4.26%)
Jun 12, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 8,057 | 7,536 | 6,933 | 6,500 | 6,591 | 8,122 |
| 8,057 | 7,536 | 6,933 | 6,500 | 6,591 | 8,122 | |
Revenue Growth (YoY) | 15.06% | 8.71% | 6.65% | -1.38% | -18.84% | 95.64% |
Cost of Revenue | 5,235 | 4,880 | 4,415 | 3,889 | 4,088 | 4,285 |
Gross Profit | 2,822 | 2,656 | 2,518 | 2,612 | 2,503 | 3,837 |
Selling, General & Admin | 1,625 | 1,631 | 1,858 | 1,802 | 2,126 | 1,773 |
Research & Development | 3,274 | 3,091 | 4,107 | 5,384 | 4,658 | 4,194 |
Amortization of Goodwill & Intangibles | 71.5 | 71.24 | 61.1 | 225.02 | 239.58 | 213.71 |
Other Operating Expenses | 74.52 | 73.3 | 71.39 | 70.9 | 80.52 | 46.36 |
Operating Expenses | 5,258 | 5,089 | 6,325 | 7,715 | 7,237 | 6,470 |
Operating Income | -2,436 | -2,433 | -3,807 | -5,104 | -4,734 | -2,633 |
Interest Expense | - | - | -259.6 | -1,526 | -1,695 | -1,241 |
Interest & Investment Income | 1,204 | 1,344 | 1,867 | 2,268 | 1,319 | 339.27 |
Currency Exchange Gain (Loss) | -57.19 | -7.49 | -103.86 | -107.29 | -9.88 | 5.72 |
Other Non Operating Income (Expenses) | 0.82 | -1 | 21.25 | 28.43 | 239.11 | 144.41 |
EBT Excluding Unusual Items | -1,288 | -1,097 | -2,281 | -4,440 | -4,880 | -3,385 |
Gain (Loss) on Sale of Investments | 10.4 | 2.86 | -13.3 | 1,952 | -2,099 | 2,486 |
Gain (Loss) on Sale of Assets | -0.05 | -0.04 | -0 | -0.04 | 25.49 | 345.31 |
Other Unusual Items | - | - | 1.86 | -352.99 | 103.58 | - |
Pretax Income | -1,278 | -1,094 | -2,293 | -2,841 | -6,850 | -553.98 |
Income Tax Expense | 279.54 | 279.54 | - | - | -12.97 | - |
Net Income | -1,557 | -1,374 | -2,293 | -2,841 | -6,837 | -553.98 |
Net Income to Common | -1,557 | -1,374 | -2,293 | -2,841 | -6,837 | -553.98 |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 9 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 9 |
Shares Change (YoY) | 2.80% | 2.74% | -0.14% | 0.46% | 3.14% | 3.23% |
EPS (Basic) | -155.31 | -137.64 | -236.00 | -292.00 | -706.00 | -59.00 |
EPS (Diluted) | -155.31 | -137.64 | -236.00 | -292.00 | -706.00 | -59.00 |
Free Cash Flow | -1,398 | -1,118 | -1,041 | -2,138 | -3,446 | -6,380 |
Free Cash Flow Per Share | -139.41 | -111.96 | -107.19 | -219.76 | -355.79 | -679.49 |
Gross Margin | 35.03% | 35.25% | 36.32% | 40.18% | 37.98% | 47.24% |
Operating Margin | -30.23% | -32.28% | -54.91% | -78.51% | -71.82% | -32.42% |
Profit Margin | -19.33% | -18.23% | -33.07% | -43.70% | -103.73% | -6.82% |
Free Cash Flow Margin | -17.35% | -14.83% | -15.02% | -32.89% | -52.28% | -78.56% |
EBITDA | -1,845 | -1,839 | -3,221 | -4,273 | -3,971 | -1,806 |
EBITDA Margin | -22.90% | -24.41% | -46.45% | -65.74% | -60.24% | -22.23% |
D&A For EBITDA | 590.75 | 593.63 | 586.08 | 830.37 | 763.09 | 827.24 |
EBIT | -2,436 | -2,433 | -3,807 | -5,104 | -4,734 | -2,633 |
EBIT Margin | -30.23% | -32.28% | -54.91% | -78.51% | -71.82% | -32.42% |
Advertising Expenses | - | 38.37 | 31.7 | 133.8 | 21.39 | 12.78 |